Enviar RFQ
EnglishEspañol
Enviar RFQ

Documento fuente o registro público

Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program

FDA source page describing its voluntary pilot program for selected oncology drugs used with in vitro diagnostic tests; participation and current status must be checked with FDA.

Technical guidanceU.S. Food and Drug Administration

Fuente

FDA is issuing this guidance to announce and describe FDA’s voluntary pilot program for certain Center for Drug Evaluation and Research (CDER)-regulated oncology drug products used with certain in vitro diagnostic tests.

fda.gov · Consultado el 2026-10-19

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated source verification

Published

2026-10-18

Updated

2026-10-20

Disclaimer

professional use

References

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Solicitar cotización

Explorar más

Misma fuente

RNA Preanalytical Systems for RT-PCR Used in Molecular Diagnostic Testing

FDA special controls source document covering RNA specimen collection, stabilization and purification systems for molecular diagnostic RT-PCR.

Misma fuente

Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions

FDA question-and-answer guidance about commercially distributed analyte specific reagents. Consult the original document and current FDA notices for applicable requirements.

Misma fuente

In Vitro Companion Diagnostic Devices

FDA guidance page for developers of therapeutic products and corresponding in vitro companion diagnostic devices.